TRNS
Get informed when a big investor buys or sells
+ FollowOvervalued by 2.1% based on the discounted cash flow analysis.
| Market cap | $789.13 Million |
|---|---|
| Enterprise Value | $925.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.67 |
| Outstanding Shares | 9,353,000 |
| P/E Ratio | 227.86 |
|---|---|
| PEG | -385.01 |
| Price to Sales | 2.28 |
| Price to Book Ratio | 2.63 |
| Enterprise Value to Revenue | 2.66 |
| Enterprise Value to EBIT | 90.41 |
| Enterprise Value to Net Income | 412 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.47 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0241▲ 2.41% |
|---|---|
| Total Calls | 169,800▲ 44.39% |
| Total Puts | 4,100▲ Infinity% |
Holdings and activity of institutional investors.
| Ownership % | 101.77%▲ 2.27% |
|---|---|
| Total Invested | $882.79M▲ 29.46% |
| Investors Holding | 177▲ 15.00% |
No data
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly t...